Literature DB >> 3654968

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

P B Watkins1, S A Wrighton, E G Schuetz, D T Molowa, P S Guzelian.   

Abstract

We used monoclonal antibodies and complementary DNAs (cDNAs) to glucocorticoid-inducible liver cytochromes P-450 in rats (P-450p) and in man (HLp) to search for related cytochromes in intestinal mucosa. In rat enterocytes, we found two dexamethasone-inducible proteins related to the steroid-inducible liver cytochromes P-450. Induction of these proteins in enterocytes was associated with increases in the amount of a P-450p-related messenger RNA and of erythromycin demethylase, an activity highly characteristic of P-450p and HLp. Similar studies on human jejunal enterocytes revealed a microsomal protein indistinguishable from HLp on immunoblots and an abundance of RNA hybridizing with HLp cDNA. In human enterocytes the specific concentration of the HLp-related cytochrome (measured immunochemically or as erythromycin demethylase activity) was similar to that found in human liver and could account for all of the CO-binding hemo-protein detected. We conclude that the intestinal mucosa contains prominent form(s) of cytochromes P-450 similar to liver cytochrome P-450p in their structure, function, and some regulatory characteristics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654968      PMCID: PMC442342          DOI: 10.1172/JCI113156

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  The excretory products of N-methyl-C14-erythromycin in rats.

Authors:  C C LEE; R C ANDERSON; K K CHEN
Journal:  J Pharmacol Exp Ther       Date:  1956-07       Impact factor: 4.030

Review 2.  Multiple forms of inducible drug-metabolizing enzymes: a reasonable mechanism by which any organism can cope with adversity.

Authors:  D W Nebert
Journal:  Mol Cell Biochem       Date:  1979-09-28       Impact factor: 3.396

3.  Differential effects of beta-naphthoflavone and pregnenolone-16alpha-carbonitrile on dimethylnitrosamine-induced hepatocarcinogenesis.

Authors:  M F Argus; C Hoch-Ligeti; J C Arcos; A H Conney
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

4.  Changes in enzyme levels accompanying differentiation of intestinal epithelial cells.

Authors:  A R Imondi; M E Balis; M Lipkin
Journal:  Exp Cell Res       Date:  1969-12       Impact factor: 3.905

Review 5.  Hormones and resistance.

Authors:  H Selye
Journal:  J Pharm Sci       Date:  1971-01       Impact factor: 3.534

6.  Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation.

Authors:  M M Weiser
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

7.  Chemical carcinogenesis in transposed intestinal segments.

Authors:  A R Gennaro; R Villanueva; Y Sukonthaman; V Vathanophas; G P Rosemond
Journal:  Cancer Res       Date:  1973-03       Impact factor: 12.701

8.  Demethylation of erythromycins by rabbit tissues in vitro.

Authors:  J C Mao; P L Tardrew
Journal:  Biochem Pharmacol       Date:  1965-07       Impact factor: 5.858

9.  Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat.

Authors:  P J Murphy; T L Williams; R E McMahon; F J Marshall
Journal:  Drug Metab Dispos       Date:  1975 May-Jun       Impact factor: 3.922

10.  Intestinal secretion of erythromycin base.

Authors:  D R Holland; J F Quay
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

View more
  95 in total

Review 1.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity.

Authors:  Donna J Belle; John T Callaghan; J Christopher Gorski; Juan F Maya; Omiema Mousa; Steven A Wrighton; Stephen D Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

3.  Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine.

Authors:  S D Raeissi; Z Guo; G L Dobson; P Artursson; I J Hidalgo
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 4.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 5.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

6.  Drug-drug interaction pattern recognition.

Authors:  John Z Duan
Journal:  Drugs R D       Date:  2010

Review 7.  [Effect of intestinal cytochrome P450 3A on phytochemical presystemic metabolism].

Authors:  Fang Xia; Xiao-yin Chen
Journal:  Chin J Integr Med       Date:  2005-09       Impact factor: 1.978

8.  Interaction between FK506 and clotrimazole in a liver transplant recipient.

Authors:  L Mieles; R Venkataramanan; I Yokoyama; V J Warty; T E Starzl
Journal:  Transplantation       Date:  1991-12       Impact factor: 4.939

9.  A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system.

Authors:  Su-Jun Lee; Ilse P van der Heiden; Joyce A Goldstein; Ron H N van Schaik
Journal:  Drug Metab Dispos       Date:  2006-10-11       Impact factor: 3.922

Review 10.  The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.

Authors:  Y Zhang; L Z Benet
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.